COVID-19 vaccine elicits antibodies in 90% taking immunosuppressants (Links to an external site)
COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted by healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.
COVID-19 vaccine generates immune structures critical for lasting immunity (Links to an external site)
Vaccines likely induce strong, persistent immunity to COVID-19
Podcast: A year later, scientists recall efforts to jump-start research into mysterious new coronavirus (Links to an external site)
This episode of ‘Show Me the Science’ details how School of Medicine scientists began working with the virus, ramping up research efforts while the rest of the world was shutting down
Wear White for a Future 2020
On June 12, 2020, the IML and the Shreiber Lab participated in Wear White for a Future. By wearing white together, we are standing for science and the search for immune-based cures. Wear White Day is critical part of June’s Cancer Immunotherapy Month awareness and education programs. #Immune2Cancer
Flu antibody protects against numerous and wide-ranging strains (Links to an external site)
A human antibody that protects mice against a wide range of lethal flu viruses could be the key to a universal vaccine and better treatments for severe flu disease, according to a new study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and […]
Clues to improve cancer immunotherapy revealed (Links to an external site)
A new School of Medicine study indicates a way for cancer immunotherapy to spur a more robust immune response. Such knowledge could lead to the development of better cancer vaccines and more effective immunotherapy drugs.
School of Medicine establishes Division of Physician-Scientists (Links to an external site)
Washington University School of Medicine in St. Louis has established a Division of Physician-Scientists to help nurture the career development of physicians who want to conduct scientific research. The new division will be headed by Wayne M. Yokoyama, MD, the Sam J. Levin and Audrey Loew Levin Professor of Arthritis Research.
Wear White for a Future (Links to an external site)
On June 14, 2019, the Shreiber Lab participated in Wear White for a Future. By wearing white together, they are standing for science and the search for immune-based cures. Wear White Day is critical part of June’s Cancer Immunotherapy Month awareness and education programs. #Immune2Cancer
A chat with the chancellor (Links to an external site)
Chancellor Mark S. Wrighton lists Bob Schreiber’s work on immunological approaches to dealing with diseases, including cancer as an accomplishment that has made one of the biggest impact during his tenure.
Schreiber elected AACR Academy fellow (Links to an external site)
Robert D. Schreiber, PhD, the Andrew M. and Jane M. Bursky Distinguished Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis, has been elected a fellow of the American Association for Cancer Research (AACR) Academy.